Med by Cell Press

Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.

[Med by Cell Press @MedCellPress]

We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: https://t.co/JGT2OpkITQ

[Med by Cell Press @MedCellPress]

Online Now: First human decedent model of orthotopic multi-organ xenotransplantation: Whole liver and bilateral kidneys from a six-gene-edited pig https://t.co/FUg6rPCHzA

[Med by Cell Press @MedCellPress]

Online Now: Capturing multi-disease states on a spectrum with machine learning and routine clinical data https://t.co/fbCewdnC01

[Med by Cell Press @MedCellPress]

Online Now: Loss of tumor suppressor NF2 mediates resistance to CAR T cell and anti-PD-1 therapy: Strategies to restore immunotherapy sensitivity https://t.co/NH3ACsLAH5

[Med by Cell Press @MedCellPress]

Online Now: Rethinking healthcare data interoperability in the age of large language models https://t.co/gnlUlfviCM

[Med by Cell Press @MedCellPress]

Online Now: Expansion of NKG2A+CD8+ T cells with regulatory signatures distinguish individuals living with HIV-2 from those with HIV-1 https://t.co/FMWmOBcR6G

[Med by Cell Press @MedCellPress]

Online Now: Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2) https://t.co/fdxVTP4zPo

[Med by Cell Press @MedCellPress]

Online Now: Impact of lead-in ADT on grade ≥3 neutropenia in patients with metastatic hormone-sensitive prostate cancer treated with triplet therapy https://t.co/y9rozc6SYw

[Med by Cell Press @MedCellPress]

Online Now: Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial https://t.co/KkjbbWRHXP

[Med by Cell Press @MedCellPress]

Online Now: Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology https://t.co/Tx6XOD5AF7

[Med by Cell Press @MedCellPress]

Online Now: Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms https://t.co/XkfQ8iQWiR

[Med by Cell Press @MedCellPress]

Online Now: Rethinking the role of synergy calculations in the next century of drug combination discovery https://t.co/8QslUd85Aa

[Med by Cell Press @MedCellPress]

Online Now: Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohort https://t.co/5MZqTyGmqN

[Med by Cell Press @MedCellPress]

Online Now: Ferroptosis in MASLD: From molecular mechanisms to therapeutic opportunities https://t.co/uCgsrZhl2w

[Med by Cell Press @MedCellPress]

Online Now: CD19 CAR-T therapy induces remission in refractory autoimmune hemolytic anemia with ITP and antiphospholipid syndrome https://t.co/BkygWnttyX

[Med by Cell Press @MedCellPress]

Online Now: Comparative efficacy of phase 2–3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysis https://t.co/ImCYjTiY0U

[Med by Cell Press @MedCellPress]

Online Now: Emerging therapeutic directions for inotropic therapy in heart failure https://t.co/CmJ204h5Z6

[Med by Cell Press @MedCellPress]

Online Now: Autism spectrum disorder in China: Clinical practices, challenges, and future https://t.co/NB1Ec6fyIX

[Med by Cell Press @MedCellPress]

Online Now: Pyramidal signs in Huntington’s disease: An early clinical indicator associated with proximity to disease onset https://t.co/O751RAQqGM

[Med by Cell Press @MedCellPress]

Online Now: Efficacy of immunotherapy rechallenge in locoregionally advanced nasopharyngeal carcinoma after progression: A real-world analysis https://t.co/J1zFGOiBIX

[Med by Cell Press @MedCellPress]

Online Now: Evaluation of recombinant human prourokinase for acute pulmonary embolism: A phase 2, randomized clinical trial https://t.co/SSPzISgTEQ